ChroniSense Medical names new CEO
20 March 2020 -

ChroniSense Medical, the developer of Polso, a wearable, medical-grade, disease management device, has named Bridget Ross as its new chief executive officer effective 10 February 2020, it was reported on Thursday.

Ross has more than three decades of strategic, operational and leadership expertise. Prior to joining ChroniSense, she was President of the global medical group at Henry Schein and a member of the company's executive management committee. She has previously served as vice president, commercial operations at Johnson & Johnson Medical Device Sector, and held multiple executive roles, including global president at two Johnson & Johnson subsidiaries, where she was responsible for the development pipeline and commercialisation of multiple innovative products.

Ilan Neugarten, chairman of the board of Rainbow Medical, ChroniSense Medical's largest investor, said, 'We are pleased Bridget will bring her talents to ChroniSense as CEO. We are confident Bridget's extensive and diverse leadership experience will deliver impactful healthcare solutions to patients and will drive ChroniSense to a leading position in the disease management space.'